Taken together, in our view, serum SCGB1A1 is a promising biomarker to detect subjects at risk of developing COPD, symptom/severity classified by GOLD criteria, and plausibly to assess the effect of treatment in people exposed to both tobacco smoke and biomass smoke. The gene discussed is SCGB1A1; the disease is chronic obstructive pulmonary disease.